Related Experiment Video

Updated: Feb 2, 2026

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

9.1K

Down-regulated G protein-coupled receptor kinase 6 leads to apoptosis in multiple myeloma MM1R cells

Zhiyao Zhang1, Zhenyu Li2, Wenming Chen1

  • 1Department of Hematology, Beijing Chao Yang Hospital, Capital Medical University, Beijing 100020, P.R. China.

Experimental and Therapeutic Medicine
|November 8, 2018
PubMed

Insights

G protein-coupled receptor kinase 6 (GRK6) is highly expressed in multiple myeloma (MM). Downregulating GRK6 promotes cancer cell death, suggesting GRK6 is crucial in MM progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • G protein-coupled receptor kinase 6 (GRK6) shows high expression in multiple myeloma (MM) cell lines.
  • GRK6 is typically absent or weakly expressed in most healthy human somatic cells.

Purpose of the Study:

  • To investigate the role of GRK6 in multiple myeloma (MM).
  • To assess GRK6 expression levels in MM patients compared to healthy individuals.
  • To evaluate the impact of GRK6 knockdown on MM cell apoptosis.

Main Methods:

  • Quantitative polymerase chain reaction (qPCR) for GRK6 expression analysis.
  • Flow cytometry to measure apoptosis in lentiviral-transfected MM1R cells.
  • Western blot analysis for apoptosis and signal transducer and activator of transcription 3 (STAT3) pathway factors.

Main Results:

  • GRK6 expression was significantly different between MM patients and healthy individuals.
  • RNA interference-mediated GRK6 knockdown induced apoptosis in the MM1R cell line.
  • GRK6 knockdown affected STAT3 pathway-related factors.

Conclusions:

  • GRK6 is differentially expressed in multiple myeloma.
  • GRK6 knockdown promotes apoptosis in MM cells, indicating a significant role in MM pathogenesis.
  • Targeting GRK6 may represent a potential therapeutic strategy for MM.
Keywords:
GRK6MM1RSTAT3apoptosismultiple myeloma

More Related Videos

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis10:04

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

13.5K
Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma07:53

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma

Published on: April 15, 2022

4.7K

Related Concept Videos

G-protein Coupled Receptors01:21

G-protein Coupled Receptors

G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
132.0K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.1K
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
17.0K
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
8.9K
Regulation of Expression Occurs at Multiple Steps02:24

Regulation of Expression Occurs at Multiple Steps

Gene expression can be regulated at almost every step from gene to protein. Transcription is the step that is most commonly regulated. This involves the binding of proteins to short regulatory sequences on the DNA. This association can either promote or inhibit the transcription of a gene associated with the respective sequence.
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
26.4K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
18.6K